The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-up
- PMID: 2037851
- DOI: 10.1016/0895-4356(91)90209-r
The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-up
Abstract
The 15 year mortality rates and causes of death are reported for the Paris Prospective Study cohort of 7180 working men, aged between 44 and 55 years who attended the first follow-up examination. All subjects were classified as normoglycaemic, impaired glucose tolerant or diabetic according to the WHO criteria, following an oral glucose tolerance test. The relative risks of death in comparison to the normoglycaemic group were 1.6 for impaired glucose tolerant and 2.3 for diabetic subjects; for death due to coronary heart disease: 1.7 and 2.3 respectively; for death due to alcohol and cirrhosis: 7.0 and 13.3 respectively. It appears that in this cohort a proportion of subjects screened as diabetic have impaired liver function and disturbed carbohydrate metabolism, due to excessive alcohol consumption. Alcohol should be investigated as a possible risk factor for diabetes, particularly in epidemiological studies where diabetes is diagnosed by the oral glucose tolerance test and the population has a high consumption of alcohol.
Similar articles
-
Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects.Diabetologia. 1992 Jan;35(1):39-44. doi: 10.1007/BF00400850. Diabetologia. 1992. PMID: 1541380
-
Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.BMJ. 1993 Jul 31;307(6899):295-9. doi: 10.1136/bmj.307.6899.295. BMJ. 1993. PMID: 8374376 Free PMC article.
-
Diabetes and pancreatic carcinoma.Diabete Metab. 1993 Sep-Oct;19(5):458-62. Diabete Metab. 1993. PMID: 8056126
-
Alcohol and liver injury: dose-related or permissive effect?Br J Addict. 1989 Jun;84(6):581-9. doi: 10.1111/j.1360-0443.1989.tb03473.x. Br J Addict. 1989. PMID: 2665882 Review.
-
The role of incretin hormones and glucagon in patients with liver disease.Dan Med J. 2017 May;64(5):B5363. Dan Med J. 2017. PMID: 28552096 Review.
Cited by
-
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.PLoS One. 2018 Apr 3;13(4):e0195028. doi: 10.1371/journal.pone.0195028. eCollection 2018. PLoS One. 2018. PMID: 29614124 Free PMC article.
-
Certification of cause of death in French diabetic patients.J Epidemiol Community Health. 1992 Feb;46(1):63-5. doi: 10.1136/jech.46.1.63. J Epidemiol Community Health. 1992. PMID: 1573362 Free PMC article.
-
The Cause-and-Effect Relationship Between Type 2 Diabetes Mellitus and Clinically Overt Cryptogenic Cirrhosis: A Matter That Must Be Seriously Revised.Hepat Mon. 2016 Aug 16;16(9):e36485. doi: 10.5812/hepatmon.36485. eCollection 2016 Sep. Hepat Mon. 2016. PMID: 27822261 Free PMC article. No abstract available.
-
Risk factors for death in men with glucose intolerance.BMJ. 1993 Aug 28;307(6903):569. doi: 10.1136/bmj.307.6903.569. BMJ. 1993. PMID: 8401007 Free PMC article. No abstract available.
-
Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?J Clin Diagn Res. 2017 Sep;11(9):OC01-OC05. doi: 10.7860/JCDR/2017/30705.10529. Epub 2017 Sep 1. J Clin Diagn Res. 2017. PMID: 29207749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical